Published in Vaccine on June 27, 2012
Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.06
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Pertussis in Poland. Int J Epidemiol (2004) 1.64
Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration (2005) 1.48
[MDR, pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009]. Pneumonol Alergol Pol (2011) 1.45
Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line. Eur J Med Chem (2007) 1.11
Synthesis and tuberculostatic activity of some (4-phenylpiperazin-1-ylmethyl)-1,3,4-oxadiazole and (4-phenylpiperazin-1-ylmethyl)-1,2,4-triazole derivatives. Acta Pol Pharm (2005) 1.02
Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol (2011) 1.01
Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland. Biologicals (2004) 0.88
[Pulmonary mycobacterioses--frequency of occurrence, clinical spectrum and predisposing factors]. Pneumonol Alergol Pol (2002) 0.82
Comparison of the (CCG)4-based PCR and MIRU-VNTR for molecular typing of Mycobacterium avium strains. Mol Biol Rep (2012) 0.82
Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol (2011) 0.82
Synthesis and antibacterial activity of 1H-pyrazolo[3,4-b]pyrazine and -pyridine derivatives. Farmaco (2005) 0.81
Bovine tuberculosis in a wild boar (Sus scrofa) in Poland. J Wildl Dis (2014) 0.81
[Amplification reaction to bacterial DNA for diagnosing infective endocarditis]. Med Dosw Mikrobiol (2002) 0.80
Development of broad-range polymerase chain reaction (PCR) bacterial identification in diagnosis of infective endocarditis. J Heart Valve Dis (2002) 0.80
[Antimycobacterial antibody level in pleural, pericardial and cerebrospinal fluid of patients with tuberculosis]. Pneumonol Alergol Pol (2004) 0.80
Synthesis and antimicrobial activity of novel heterocyclic sulfamoyl-phenyl-carboximidamides derived from clinically applied sulfonamides. Arch Pharm (Weinheim) (2012) 0.80
Amplified fragment length polymorphism (AFLP) versus randomly amplified polymorphic DNA (RAPD) as new tools for inter- and intra-species differentiation within Bordetella. J Med Microbiol (2005) 0.80
[Analysis of the frequency of isolation and drug resistance of microorganisms isolated from the airways of adult CF patients treated in the Institute of Tuberculosis and Lung Disease during 2008-2011]. Pneumonol Alergol Pol (2013) 0.79
Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Pneumonol Alergol Pol (2013) 0.78
Profiling Mycobacterium xenopi with restriction fragment length polymorphism of insertion element IS1395. Int J Infect Dis (2011) 0.78
[Transmission of Mycobacterium tuberculosis among household contacts of patients with tuberculosis]. Przegl Epidemiol (2008) 0.78
[The biological role of prokaryotic and eukaryotic N-acetyltransferase]. Pneumonol Alergol Pol (2013) 0.77
Synthesis of isomeric, oxathiolone fused chalcones, and comparison of their activity toward various microorganisms and human cancer cells line. Chem Pharm Bull (Tokyo) (2007) 0.77
Human as a source of tuberculosis for cattle. First evidence of transmission in Poland. Vet Microbiol (2012) 0.76
A two-step strategy for molecular typing of multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland. Pol J Microbiol (2011) 0.76
[Epidemiology of tuberculosis: a global, European and Polish perspective]. Wiad Lek (2010) 0.76
[Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland]. Pneumonol Alergol Pol (2010) 0.76
Benign paroxysmal vertigo of childhood. Otolaryngol Pol (2007) 0.75
Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study. Pol Arch Med Wewn (2016) 0.75
Lipoarabinomannan as a regulator of the monocyte apoptotic response to Mycobacterium bovis BCG Danish strain 1331 infection. Pol J Microbiol (2007) 0.75
Application of the MALDI-TOF for identification of Clostridium perfringens strains. Med Dosw Mikrobiol (2017) 0.75
[Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products]. Med Dosw Mikrobiol (2013) 0.75
The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule. Acta Pol Pharm (2003) 0.75
[Extrapulmonary tuberculosis: case of a 70-year-old woman suffering from cutaneous lymph node, renal and bone tuberculosis ]. Pol Arch Med Wewn (2004) 0.75
[Genetic variability of Bordetella pertussis strains. Part I. Current knowledge]. Przegl Epidemiol (2003) 0.75
[Polymorphism analysis of Haemophilus influenzae strains isolated from healthy children with respect to amplification reaction]. Med Dosw Mikrobiol (2003) 0.75
[Granuloma of epididymis of patient treated with intravesical BCG therapy--complication of BCG therapy or tuberculosis?]. Pneumonol Alergol Pol (2011) 0.75
[The studies of elimination of nontypeable Haemophilus influenzae strains using the animal model of infection]. Med Dosw Mikrobiol (2013) 0.75
[Genotyping of Mycobacterium tuberculosis. An overview of the major research techniques (Part I)]. Pol Merkur Lekarski (2010) 0.75
[Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection]. Pneumonol Alergol Pol (2011) 0.75
Erratum: Global phylogeography and evolutionary history of Shigella dysenteriae type 1. Nat Microbiol (2016) 0.75
[Mycolic acids analysis from various species mycobacterium by high pressure liquid chromatography (HPLC)]. Pneumonol Alergol Pol (2002) 0.75
[Genetic variability of Bordetella pertussis strains. Part II. Perspectives]. Przegl Epidemiol (2003) 0.75
[Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice]. Med Dosw Mikrobiol (2007) 0.75
[Drug resistant tuberculosis]. Pol Merkur Lekarski (2011) 0.75
[Broad-range fungal PCR in diagnosis of complicated infective endocarditis]. Pol Arch Med Wewn (2002) 0.75
Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model. Vaccine (2011) 0.75
[Genotyping of Mycobacterlum tuberculosis. An overview of the major research techniques (Part II)]. Pol Merkur Lekarski (2010) 0.75
[Humoral immune response against mycobacterial antigens in patients with tuberculosis and mycobacterial infections other than tuberculosis]. Pneumonol Alergol Pol (2006) 0.75
Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland. Arch Immunol Ther Exp (Warsz) (2014) 0.75
Mechanism of Vipera berus venom activity and the principles of antivenom administration in treatment. Przegl Epidemiol (2013) 0.75
[Application of DNA microcarriers for evaluation of mice splenocytes genes expression after immunization with pertussis vaccines and challenged with different B. pertussis strains]. Med Dosw Mikrobiol (2007) 0.75
[Evaluation of humoral immune response against mycobacterial antigens in bronchoalveolar lavage fluid from patients with pulmonary tuberculosis confirmed by genetic and culture methods]. Pneumonol Alergol Pol (2007) 0.75
[Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population]. Pneumonol Alergol Pol (2007) 0.75
The rate of adverse events following BCG vaccination in Poland. Przegl Epidemiol (2012) 0.75
[Bacteriologically confirmed pulmonary tuberculosis in a patient with lymphangioleiomyomatosis accompanying tuberous sclerosis syndrome]. Pneumonol Alergol Pol (2011) 0.75
Gene expression profiling of lipoarabinomannan-treated mouse macrophage cultures infected with Mycobacterium bovis BCG. Pol J Microbiol (2008) 0.75
[Diagnostic methods of postvaccinal complications after administration of BCG vaccine]. Przegl Epidemiol (2004) 0.75
[Modern microbiological methods in diagnosis of adverse reactions after BCG vaccination. Case reports]. Pneumonol Alergol Pol (2004) 0.75
[Parental attitudes towards childhood immunisations in Poland]. Przegl Epidemiol (2010) 0.75
PCR-based genomic deletion analysis of RD-regions in the identification of mycobacteria isolated from adverse events following BCG vaccination or TB suspected cases. Pol J Microbiol (2014) 0.75
[Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part II. Consistency of control and production]. Przegl Epidemiol (2004) 0.75
Relationship between past myocardial infarction, periodontal disease and Porphyromonas gingivalis serum antibodies: A case-control study. Cardiol J (2017) 0.75
[Susceptibility of Lactobacillus rhamnosus strains isolated from probiotic products to antimicrobial agents]. Med Dosw Mikrobiol (2015) 0.75
The capacity of Mycobacterium tuberculosis complex species and M. bovis BCG substrains specific identification - implications for optimized PCR-based diagnostics in adverse events following vaccination suspected cases. Pol J Microbiol (2012) 0.75
Synthesis of 2,3-dihydro-7-nitroimidazo[5,1-b]oxazoles as potential tuberculostatic agents. Acta Pol Pharm (2008) 0.75
[Sources of information and knowledge on childhood immunisations among Polish parents]. Przegl Epidemiol (2010) 0.75
Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants. Biologicals (2013) 0.75
Association between central and peripheral blood pressure and periodontal disease in patients with a history of myocardial infarction. Pol Arch Med Wewn (2016) 0.75
The possible effect of a sanitization program on intraspecies differentiation of Listeria monocytogenes strains isolated from a fish processing plant. Int J Hyg Environ Health (2003) 0.75
[Detection of the adventitious agents in the evaluation of vaccine safety]. Przegl Epidemiol (2012) 0.75
[Epidemiology of drug-resistant tuberculosis: world--Europe--Poland]. Wiad Lek (2010) 0.75
[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults]. Przegl Epidemiol (2012) 0.75
Effectiveness of experimental whole-cell pertussis vaccines in murine model. Med Dosw Mikrobiol (2014) 0.75
[Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines]. Med Dosw Mikrobiol (2014) 0.75
[Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part I. Potency of DTP vaccine]. Przegl Epidemiol (2004) 0.75
Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety. Acta Pol Pharm (2007) 0.75
[Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations]. Med Dosw Mikrobiol (2007) 0.75
[Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases]. Pneumonol Alergol Pol (2004) 0.75